ReviewDrug design, development and therapy2022

Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung Disease.

Rongxiu Huo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.